FINWIRES · TerminalLIVE
FINWIRES

$GMRS

11 stories mentioning GMRSUpdated just now

Every FINWIRES story that references GMRS, newest first.

What are analysts saying about GMRS?

Recent broker actions mentioned in FINWIRES coverage. Compiled from wire headlines; not investment advice.

What's the latest news on GMRS?

Insider Trading

Gmr Solutions Insider Sold Shares Worth $3,199,792, According to a Recent SEC Filing

Edward Van Horne, President and Chief Operating Officer, on September 14, 2026, sold 262,278 shares in Gmr Solutions (GMRS) for $3,199,792. Following the Form 4 filing with the SEC, Van Horne has control over a total of 575,004 Class A common shares of the company, with 575,004 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1898718/000110465926107672/xslF345X05/tm2625330-6_4seq1.xml

$GMRS
Insider Trading

Gmr Solutions Insider Sold Shares Worth $3,242,687, According to a Recent SEC Filing

Brian Scott Tierney, Executive Vice President and Chief Financial Officer, on September 14, 2026, sold 265,794 shares in Gmr Solutions (GMRS) for $3,242,687. Following the Form 4 filing with the SEC, Tierney has control over a total of 554,955 Class A common shares of the company, with 554,955 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1898718/000110465926107669/xslF345X05/tm2625330-5_4seq1.xml

$GMRS
Wire

GMR Solutions Faces Margin Expansion Opportunities Amid Tough Backdrop, Morgan Stanley Says

GMR Solutions (GMRS) is well positioned to capitalize on margin expansion opportunities in a "challenging" US emergency medical services market, though investors may need "several quarters" of consistent execution before sentiment improves, Morgan Stanley said in a note Monday.The investment firm highlighted GMR's leadership position in ground and air emergency medical services, serving about 1,400 counties and roughly 200 million Americans. An aging population and rising prevalence of chronic conditions are expected to support long-term demand for EMS services, Morgan Stanley said.The note pointed to margin expansion opportunities, strong free cash flow generation, and a robust acquisition pipeline in a highly fragmented EMS industry, with the firm expecting cash flow growth to support deleveraging and future mergers and acquisitions.Despite its market leadership and growth prospects, the firm said GMR remains a "show me" story amid a challenging healthcare environment and weak investor sentiment, warning that operational missteps could weigh on the stock.Morgan Stanley initiated GMR Solutions with an equal-weight rating and a $14 price target.Shares of GMR Solutions were up more than 2% in Monday trading.Price: $11.14, Change: $+0.24, Percent Change: +2.20%

$GMRS
Research

Update: Morgan Stanley Initiates GMR Solutions at Equalweight With $14 Price Target

(Updates to add price target.)

$GMRS
Research

Evercore ISI Initiates GMR Solutions at Outperform With $20 Price Target

$GMRS
Research

Citigroup Initiates GMR Solutions at Buy With $17 Price Target

$GMRS
Research

Goldman Sachs Initiates GMR Solutions at Buy With $35 Price Target

$GMRS
Research

JPMorgan Initiates GMR Solutions at Overweight With $15 Price Target

$GMRS
Research

UBS Initiates GMR Solutions at Buy With $20 Price Target

$GMRS
Research

Morgan Stanley Initiates GMR Solutions at Equalweight

$GMRS
Research

Barclays Initiates GMR Solutions at Overweight With $16 Price Target

$GMRS

Track with the FINWIRES app suite